InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
0.00%
)
US TECH 100
18,204.40
(
0.32%
)
Dow Jones
39,065.26
(
0.00%
)
Brent Oil
81.41
(
0.12%
)
Bitcoin
67,332.91
(
-0.87%
)
Post# of 7503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Emannow

Send PM Follow Ignore
Followers 9
Posts 374
Boards Moderated 0
Alias Born 09/01/2021

Emannow

Re: iwfal post# 7349

Friday, 05/10/2024 7:49:48 PM

Friday, May 10, 2024 7:49:48 PM

Post# of 7503
RVNC has many avenues if management needs to make a change:
- sell the entire company
- sell the aesthetic FDA approval
- sell the CD Therapeutic approval
- sell the manufacturing patents for Daxi
- sell the rights to generic Botox
- etc....

There are many avenues which could be used if needed.

Sadly, Fooly does not care about the SP...he is 100% focused on fixing the issues that Premium Pricing Strategy caused! I am with Dew and believe Therapeutic Daxi sales will be strong and profitability will be reached without any additional avenues.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RVNC News
More RVNC News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!